Heyu Biological Technology Corp (HYBT) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
4TH FLOOR, NO.10 BUILDING, XINGLIN BAY XIAMEN CITY, FUJIAN PROVINCE, 361022 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 6 | 29 | 11 | 2 | 2 | 4 | |||
| Cash and cash equivalents | 6 | 29 | 11 | 2 | 2 | 4 | |||
| Receivables | 23 | 24 | 18 | 24 | 33 | 27 | |||
| Inventory, net of allowances, customer advances and progress billings | 0 | ||||||||
| Inventory | 0 | ||||||||
| Prepaid expense | |||||||||
| Deferred costs | |||||||||
| Advances on inventory purchases | 3 | 3 | 3 | 3 | 3 | 3 | |||
| Other current assets | |||||||||
| Other undisclosed current assets | |||||||||
| Total current assets: | 32 | 57 | 32 | 29 | 38 | 34 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 169 | 193 | 13 | 35 | |||||
| Property, plant and equipment | |||||||||
| Other noncurrent assets | 23 | 14 | |||||||
| Other undisclosed noncurrent assets | |||||||||
| Total noncurrent assets: | 191 | 206 | 13 | 35 | |||||
| Other undisclosed assets | (0) | ||||||||
| TOTAL ASSETS: | 224 | 263 | 32 | 29 | 51 | 69 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 142 | 200 | 301 | 343 | 400 | 317 | |||
| Taxes payable | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 0 | ||
| Accounts payable | 16 | 16 | 16 | 16 | 17 | 17 | |||
| Accrued liabilities | 126 | 183 | 285 | 327 | 384 | 300 | |||
| Deferred revenue | 417 | 438 | 435 | 422 | 448 | 473 | |||
| Debt | 1,269 | ||||||||
| Other liabilities | 417 | 438 | |||||||
| Due to related parties | ✕ | ✕ | ✕ | 422 | 448 | 473 | |||
| Other undisclosed current liabilities | 1,400 | 1,201 | 0 | 655 | 643 | 669 | |||
| Total current liabilities: | 2,375 | 2,276 | 2,005 | 1,842 | 1,939 | 1,932 | |||
| Noncurrent Liabilities | |||||||||
| Liabilities, other than long-term debt | 93 | 112 | |||||||
| Operating lease, liability | 93 | 112 | |||||||
| Total noncurrent liabilities: | 93 | 112 | |||||||
| Total liabilities: | 2,467 | 2,389 | 2,005 | 1,842 | 1,939 | 1,932 | |||
| Equity | |||||||||
| Equity, attributable to parent | (2,012) | (1,857) | (1,757) | (1,590) | (1,680) | (1,669) | |||
| Common stock | 103 | 1,032 | 1,032 | 1,032 | 1,032 | 1,032 | |||
| Additional paid in capital | 18,078 | 17,149 | 17,149 | 17,149 | 17,149 | 17,149 | |||
| Accumulated other comprehensive income (loss) | 34 | (3) | (52) | (6) | (95) | (180) | |||
| Accumulated deficit | (20,228) | (20,035) | (19,887) | (19,765) | (19,766) | (19,671) | |||
| Equity, attributable to noncontrolling interest | (231) | (269) | (215) | (222) | (208) | (194) | |||
| Total equity: | (2,244) | (2,126) | (1,973) | (1,813) | (1,888) | (1,863) | |||
| TOTAL LIABILITIES AND EQUITY: | 224 | 263 | 32 | 29 | 51 | 69 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 6 | 10 | 50 | 14 | 15 | |||
| Cost of revenue | (1) | (1) | (18) | (4) | (6) | |||
| Gross profit: | 6 | 9 | 32 | 10 | 10 | |||
| Operating expenses | (198) | (157) | (154) | (2) | (105) | (59) | ||
| Other operating income, net | ||||||||
| Other undisclosed operating loss | ||||||||
| Operating loss: | (193) | (149) | (121) | (2) | (95) | (50) | ||
| Nonoperating income | 0 | 0 | 0 | 0 | 0 | |||
| Loss from continuing operations before equity method investments, income taxes: | (192) | (148) | (121) | (2) | (95) | (50) | ||
| Other undisclosed income from continuing operations before income taxes | ||||||||
| Loss from continuing operations before income taxes: | (192) | (148) | (121) | (2) | (95) | (50) | ||
| Income tax expense | ||||||||
| Loss from continuing operations: | (192) | (148) | (121) | (2) | (95) | (50) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | (50) | |
| Net loss available to common stockholders, diluted: | (192) | (148) | (121) | (2) | (95) | (50) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (192) | (148) | (121) | (2) | (95) | (50) | ||
| Other comprehensive income (loss) | (5) | (46) | 85 | 85 | (38) | |||
| Other undisclosed comprehensive income | 75 | |||||||
| Comprehensive income (loss): | (118) | (153) | (167) | 84 | (10) | (88) | ||
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | (38) | 54 | (0) | 34 | ||||
| Other undisclosed comprehensive loss, net of tax, attributable to parent | ||||||||
| Comprehensive income (loss), net of tax, attributable to parent: | (156) | (99) | (167) | 84 | (10) | (54) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.